Home | Sitemap | Search | ContactA- A A+
   
 
    Public Member Support us  
 

Trial IX 

Adjuvant therapy in postmenopausal patients with node negative breast cancer: tamoxifen vs. CMF + tamoxifen

DESIGN

Design Trial IX

Results & Publications


Presentations


Publications

Study Chair
Prof. Monica Castiglione - Bern, Switzerland

Statistician
Dr. Meredith Regan

Lead Trial Coordinator
Holly Shaw

Director of Data Management
Lynette Blacher

IBCSG Data Management Center/FSTRF
4033 Maple Road
Amherst, New York 14226 USA
Phone: +1 716 834 0900
Fax: +1 716 833 3990
Email: ibcsgVI-IX@fstrf.org

Date of Activation
October 1, 1988

Date of Closure
August 1, 1999

Targeted Accrual
1600 patients

Final Accrual
1715 patients


Results Publications Results & Publications
Other Pathology


News

14.06.2020:
Save the date and join the IBCSG Pink Ladies! June 14, 2020

20.03.2020:
The next IBCSG Annual Meeting will take place in Barcelona Spain on March 20 and 21, 2020.       

11.11.2019:
New publications are available 

All News

 
  Print